Detalles de la búsqueda
1.
Final 5-year report of BIONYX comparing the thin-composite wire-strut zotarolimus-eluting stent versus ultrathin-strut sirolimus-eluting stent.
Catheter Cardiovasc Interv
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38713843
2.
Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials.
Neth Heart J
; 32(6): 254-261, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38776038
3.
Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.
Catheter Cardiovasc Interv
; 102(2): 221-232, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37232278
4.
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials.
Cardiovasc Diabetol
; 20(1): 217, 2021 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34717627
5.
Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial.
Catheter Cardiovasc Interv
; 98(2): E188-E196, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33694294
6.
First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial.
Circ J
; 85(11): 1983-1990, 2021 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34261828
7.
New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials.
Am Heart J
; 228: 109-115, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32882569
8.
Three contemporary thin-strut drug-eluting stents implanted in severely calcified coronary lesions of participants in a randomized all-comers trial.
Catheter Cardiovasc Interv
; 96(5): E508-E515, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32237060
9.
Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
Catheter Cardiovasc Interv
; 96(2): E110-E118, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31625262
10.
Drug-eluting stents for ST-segment elevation myocardial infarction: extending the biodegradable versus durable polymer debate.
Lancet
; 402(10416): 1942-1943, 2023 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37898136
11.
Invasiveness of previous treatment for peripheral arterial disease and risk of adverse cardiac events after coronary stenting.
Cardiovasc Interv Ther
; 39(2): 173-182, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353865
12.
Lack of Evidence Regarding Markers Identifying Acute Heart Failure in Patients with COPD: An AI-Supported Systematic Review.
Int J Chron Obstruct Pulmon Dis
; 19: 531-541, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38414719
13.
Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease.
Atherosclerosis
; 392: 117488, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598970
14.
First myocardial infarction in patients with premature coronary artery disease: insights into patient characteristics and outcome after treatment with contemporary stents.
Eur Heart J Acute Cardiovasc Care
; 12(11): 774-781, 2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37619976
15.
Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention.
Front Cardiovasc Med
; 10: 1160201, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37745109
16.
Exploring Patterns of COPD Exacerbations and Comorbid Flare-Ups.
Int J Chron Obstruct Pulmon Dis
; 18: 2633-2644, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38022827
17.
Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease.
Int J Cardiol
; 374: 27-32, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36496036
18.
Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials.
Cardiovasc Diagn Ther
; 13(4): 673-685, 2023 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37675090
19.
Use of the Left Radial Artery as Vascular Access for Coronary Angiography and as a Bypass Conduit: A Clinical Dilemma?
Cardiovasc Revasc Med
; 34: 134-139, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33485859
20.
Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials.
Atherosclerosis
; 355: 52-59, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641327